Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

6.3K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.3K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

52
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
52
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

135
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
135
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

330
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
330
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

2.9K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
2.9K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

3.5K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 Induction.

Journal of medicinal chemistry·2026
Same author

Benzo[a]pyrene-induced AHR activation in human ESCs primes premature neurogenesis in brain organoids.

bioRxiv : the preprint server for biology·2026
Same author

Stability of extemporaneously compounded cobimetinib oral suspensions.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp-overexpressing cancer models.

Molecular cancer therapeutics·2026
Same author

Label-Free High-Throughput Screening of CYP3A4 Inhibitors Using Acoustic Ejection Mass Spectrometry.

Analytical chemistry·2026
Same author

A Driver Screening Method Based on Perception Ability Test of Dangerous Omen.

Sensors (Basel, Switzerland)·2026

相关实验视频

Updated: May 15, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

9.7K

解码 CYP3A4 的选择性化学调制.

Jingheng Wang1, Stanley Nithianantham1, Sergio C Chai1

  • 1Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.

Nature communications
|April 10, 2025
PubMed
概括

开发选择性抑制剂对细胞染色体P450 3A4 (CYP3A4) 是具有挑战性的,因为其与CYP3A5.5的相似性. 这项研究提出了新型选择性CYP3A4抑制剂,为改善药物的疗效和安全提供了一条道路.

更多相关视频

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.4K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.6K

相关实验视频

Last Updated: May 15, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

9.7K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.4K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.6K

科学领域:

  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.
  • 药用化学 医学化学

背景情况:

  • 药物相互作用在多药学中很常见.
  • 细胞染色体P450 3A4 (CYP3A4) 是药物代谢中的一个关键酶.
  • 像利托纳维尔这样的泛-CYP3A抑制剂也被使用,但缺乏选择性.

研究的目的:

  • 开发针对CYP3A4而不是CYP3A5.5选择性的新型抑制剂.
  • 了解CYP3A4选择性的结构基础.
  • 为了指导改进的CYP3A4选择性抑制剂的设计.

主要方法:

  • 高通量选以确定初始抑制剂支架.
  • 酶-抑制剂相互作用的结构,功能和计算分析.
  • 以结构为指导的设计和新型类型的合成.

主要成果:

  • 确定了选择性CYP3A4抑制剂支架.
  • 为选择性而阐明的结构决定因素 (C端环,结合面).
  • 经过验证的基于结构的设计与类似物显示高CYP3A4与CYP3A5选择性.
  • 对其他主要的P450酶具有被证明的选择性.

结论:

  • 选择性抑制CYP3A4是可行的.
  • 在CYP3A4和CYP3A5之间存在不同的结构特征,使其具有选择性.
  • 为设计下一代CYP3A4选择性抑制剂提供了一个框架,以实现更安全的药物组合.